An in-vitro assay using human spermatozoa to detect toxicity of biologically active substances
- Sprache
-
Englisch
- Identifier
-
1243437871
Beteiligte Personen und Organisationen
Vollmer, Tino
Ljungberg, Börje
Jankowski, Vera
Jankowski, Joachim
Glorieux, Griet
Stegmayr, Bernd G.
Ljungberg, Börje
Jankowski, Vera
Jankowski, Joachim
Glorieux, Griet
Stegmayr, Bernd G.
- DOI
-
10.18154/RWTH-2020-01908
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:56 MEZ
Beteiligte
- Vollmer, Tino
- Ljungberg, Börje
- Jankowski, Vera
- Jankowski, Joachim
- Glorieux, Griet
- Stegmayr, Bernd G.
Ähnliche Objekte (12)
Development of a MALDI MS-based platform for early detection of acute kidney injury
Irreversible post-translational modifications – Emerging cardiovascular risk factors
Reproducibility Evaluation of Urinary Peptide Detection Using CE-MS
Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker
Collagen-Derived Peptides in CKD: A Link to Fibrosis
Reduction of protein-bound uraemic toxins in plasma of chronic renal failure patients : A systematic review
Sample preparation of formalin-fixed paraffin-embedded tissue sections for MALDI-mass spectrometry imaging
Registration of Image Modalities for Analyses of Tissue Samples Using 3D Image Modelling
Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach
Human plasma proteomics for the identification of novel substances involved in the pathogenesis of chronic kidney disease using mass spectrometric approach
Uremic Toxins and Ciprofloxacin Affect Human Tenocytes In Vitro
Gut-liver crosstalk: Effect of the transjugular intrahepatic portosystemic shunt on peptidomics composition of peripheral plasma
Development of a MALDI MS-based platform for early detection of acute kidney injury
Irreversible post-translational modifications – Emerging cardiovascular risk factors
Reproducibility Evaluation of Urinary Peptide Detection Using CE-MS
Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker
Collagen-Derived Peptides in CKD: A Link to Fibrosis
Reduction of protein-bound uraemic toxins in plasma of chronic renal failure patients : A systematic review
Sample preparation of formalin-fixed paraffin-embedded tissue sections for MALDI-mass spectrometry imaging
Registration of Image Modalities for Analyses of Tissue Samples Using 3D Image Modelling
Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach
Human plasma proteomics for the identification of novel substances involved in the pathogenesis of chronic kidney disease using mass spectrometric approach
Uremic Toxins and Ciprofloxacin Affect Human Tenocytes In Vitro
Gut-liver crosstalk: Effect of the transjugular intrahepatic portosystemic shunt on peptidomics composition of peripheral plasma
Development of a MALDI MS-based platform for early detection of acute kidney injury
Irreversible post-translational modifications – Emerging cardiovascular risk factors
Reproducibility Evaluation of Urinary Peptide Detection Using CE-MS
Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker
Collagen-Derived Peptides in CKD: A Link to Fibrosis
Reduction of protein-bound uraemic toxins in plasma of chronic renal failure patients : A systematic review
Sample preparation of formalin-fixed paraffin-embedded tissue sections for MALDI-mass spectrometry imaging
Registration of Image Modalities for Analyses of Tissue Samples Using 3D Image Modelling
Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach
Human plasma proteomics for the identification of novel substances involved in the pathogenesis of chronic kidney disease using mass spectrometric approach
Uremic Toxins and Ciprofloxacin Affect Human Tenocytes In Vitro